Company Filing History:
Years Active: 2007
Title: Unveiling the Innovation of Conor J MacEvilly: Pioneering Mucosal Delivery of Y2 Receptor-Binding Peptides
Introduction: Conor J MacEvilly, a brilliant inventor based in Seattle, WA, has made significant strides in the realm of pharmaceutical compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides. With three patents under his belt, Conor is a trailblazer in the field of treating and preventing obesity through innovative medical solutions.
Latest Patents: Conor's recent patents revolve around "Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity." These patents describe pharmaceutical compositions that incorporate Y2 receptor-binding peptides, such as peptide YY (PYY), Neuropeptide Y (NPY), or Pancreatic Peptide (PP), along with mucosal delivery-enhancing agents. By focusing on enhanced nasal mucosal delivery of peptide YY, Conor's inventions offer new avenues for treating a variety of diseases and conditions in mammalian subjects, particularly obesity.
Career Highlights: Conor J MacEvilly has been a pivotal figure at Nastech Pharmaceutical Company, Inc., where his groundbreaking research and innovative approaches have propelled the company's efforts in developing cutting-edge pharmaceutical solutions. His expertise in drug delivery mechanisms has garnered widespread recognition in the scientific community.
Collaborations: Alongside esteemed colleagues such as Steven C Quay and Gordon Brandt, Conor has fostered a collaborative environment at Nastech Pharmaceutical Company, Inc., where innovative ideas flourish, leading to the successful implementation of novel drug delivery systems.
Conclusion: In conclusion, Conor J MacEvilly's inventive spirit and dedication to advancing pharmaceutical science have redefined the landscape of mucosal delivery of Y2 receptor-binding peptides. His contributions not only hold immense promise for treating obesity but also underscore the transformative power of innovation in the realm of medical research.